Why medical care costs in Japan have increased despite declining prices for pharmaceuticals

Naoki Ikegami

研究成果: Article査読

12 被引用数 (Scopus)

抄録

Analysis of the 1979 to 1993 surveys of national claims data shows that, using deflated prices, most of the increase in outpatient care costs is due to drugs, with increases in gross volume and deflated unit prices making equal contributions. Further analysis of detailed prescriptions data obtained from one-tenth of the total sample for 1991 and 1993 reveals that new drugs and originator drugs tend to be selected more often. The present vicious cycle of high launch prices, followed by subsequent cuts in the fee schedule, has led to adverse consequences for the industry, physicians and patients.

本文言語English
ページ(範囲)97-105
ページ数9
ジャーナルPharmacoEconomics
14
SUPPL. 1
DOI
出版ステータスPublished - 1998 1 1

ASJC Scopus subject areas

  • 薬理学
  • 健康政策
  • 公衆衛生学、環境および労働衛生

フィンガープリント

「Why medical care costs in Japan have increased despite declining prices for pharmaceuticals」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル